UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy

Molecules (Basel, Switzerland), 2017-01, Vol.22 (1), p.76

2017

Link zum Volltext

Verfügbarkeit prüfen

Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies

CNS & neurological disorders drug targets, 2013-08, Vol.12 (5), p.680

2013

Link zum Volltext

Verfügbarkeit prüfen

Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases

Natural product reports, 2014-01, Vol.31 (1), p.19-139

2014

Link zum Volltext

Verfügbarkeit prüfen

Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease

Mediators of Inflammation, 2013-01, Vol.2013, p.952375-12

2013

Link zum Volltext

Verfügbarkeit prüfen

Toxin-Induced Experimental Models of Learning and Memory Impairment

International journal of molecular sciences, 2016-09, Vol.17 (9), p.1447-1447

2016

Link zum Volltext

Verfügbarkeit prüfen

Anti-neuroinflammatory Activity of a Novel Cannabinoid Derivative by Inhibiting the NF-κB Signaling Pathway in Lipopolysaccharide-Induced BV-2 Microglial Cells

Journal of Pharmacological Sciences, 2013/02/20, Vol.121(2), pp.119-130

2013

Link zum Volltext

Verfügbarkeit prüfen

The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism

International Journal of Molecular Sciences, 2012-08, Vol.13 (8), p.10478-10504

2012

Link zum Volltext

Verfügbarkeit prüfen

Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death

International journal of molecular sciences, 2017-05, Vol.18 (5), p.1012

2017

Link zum Volltext

Verfügbarkeit prüfen

Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson’s Disease Model

Evidence-based complementary and alternative medicine, 2013-01, Vol.2013, p.514095-13

2013

Link zum Volltext

Verfügbarkeit prüfen

The role of bioactive compounds on the promotion of neurite outgrowth

Molecules, 2012-06, Vol.17 (6), p.6728-6753

2012

Link zum Volltext

Verfügbarkeit prüfen

Promising therapeutics with natural bioactive compounds for improving learning and memory--a review of randomized trials

Molecules, 2012-09, Vol.17 (9), p.10503-10539

2012

Link zum Volltext

Verfügbarkeit prüfen

β-Asarone (cis-2,4,5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-κB signaling and the JNK pathway in LPS activated BV-2 microglia cells

Food and chemical toxicology, 2014-10, Vol.72, p.265-272

2014

Link zum Volltext

Verfügbarkeit prüfen

A novel synthetic compound MCAP suppresses LPS- induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways

Acta pharmacologica Sinica, 2016-03, Vol.37 (3), p.334-343

2016

Link zum Volltext

Verfügbarkeit prüfen

Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease

International Journal of Molecular Sciences, 2012-08, Vol.13 (8), p.10608-10629

2012

Link zum Volltext

Verfügbarkeit prüfen

Traditional Korean East Asian medicines and herbal formulations for cognitive impairment

Molecules, 2013-11, Vol.18 (12), p.14670-14693

2013

Link zum Volltext

Verfügbarkeit prüfen

Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease

Molecules, 2012-09, Vol.17 (10), p.11391-11420

2012

Link zum Volltext

Verfügbarkeit prüfen

EOP, a newly synthesized ethyl pyruvate derivative, attenuates the production of inflammatory mediators via p38, ERK and NF-κB pathways in lipopolysaccharide-activated BV-2 microglial cells

Molecules (Basel, Switzerland), 2014-11, Vol.19 (12), p.19361-19375

2014

Link zum Volltext

Verfügbarkeit prüfen

Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation

Brain research bulletin, 2015-03, Vol.112, p.25-34

2015

Link zum Volltext

Verfügbarkeit prüfen

Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection

Molecular neurodegeneration, 2015-04, Vol.10 (1), p.17-17, Article 17

2015

Link zum Volltext

Verfügbarkeit prüfen

Emerging preclinical pharmacological targets for Parkinson's disease

Oncotarget, 2016-05, Vol.7 (20), p.29835-29863

2016

Link zum Volltext

Verfügbarkeit prüfen

Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson’s Disease

Evidence-based complementary and alternative medicine, 2013-01, Vol.2013, p.957875-15

2013

Link zum Volltext

Verfügbarkeit prüfen

A novel synthetic HTB derivative, BECT inhibits lipopolysaccharide-mediated inflammatory response by suppressing the p38 MAPK/JNK and NF-κB activation pathways

Pharmacological reports, 2014-06, Vol.66 (3), p.471-479

2014

Link zum Volltext

Verfügbarkeit prüfen

EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-[kappa]B Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells

Molecules (Basel, Switzerland), 2014-12, Vol.19 (12), p.19361

2014

Link zum Volltext

Verfügbarkeit prüfen

Anti-neuroinflammatory Activity of a Novel Cannabinoid Derivative by Inhibiting the NF-кB Signaling Pathway in Lipopolysaccharide-Induced BV-2 Microglial Cells

Journal of Pharmacological Sciences, 2013-02, Vol.121 (2), p.119-130

2013

Link zum Volltext

Verfügbarkeit prüfen

Practical multidisciplinary framework for the assessment and management of patients with unexplained chronic aerodigestive symptoms

BMJ open gastroenterology, 2023-11, Vol.10 (1), p.e000883

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(34)
Humans
(20)
Animals
(17)
Physical Sciences
(14)
Chemistry
(13)
Biochemistry & Molecular Biology
(12)
Chemistry, Multidisciplinary
(12)
Review
(12)
Parkinson's Disease
(9)
Mice
(7)
Microglia
(7)
Cell Line
(6)
Microglia - Drug Effects
(6)
Neuroinflammation
(6)
Neuroprotection
(6)
Signal Transduction - Drug Effects
(6)
Neuroprotective Agents - Pharmacology
(5)
Neurosciences
(5)
Nf-Kappa B - Metabolism
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy

Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies

Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases

Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease

Toxin-Induced Experimental Models of Learning and Memory Impairment

Anti-neuroinflammatory Activity of a Novel Cannabinoid Derivative by Inhibiting the NF-κB Signaling Pathway in Lipopolysaccharide-Induced BV-2 Microglial Cells

The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism

Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death

Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson’s Disease Model

The role of bioactive compounds on the promotion of neurite outgrowth

Promising therapeutics with natural bioactive compounds for improving learning and memory--a review of randomized trials

β-Asarone (cis-2,4,5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-κB signaling and the JNK pathway in LPS activated BV-2 microglia cells

A novel synthetic compound MCAP suppresses LPS- induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways

Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease

Traditional Korean East Asian medicines and herbal formulations for cognitive impairment

Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease

EOP, a newly synthesized ethyl pyruvate derivative, attenuates the production of inflammatory mediators via p38, ERK and NF-κB pathways in lipopolysaccharide-activated BV-2 microglial cells

Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation

Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection

Emerging preclinical pharmacological targets for Parkinson's disease

Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson’s Disease

A novel synthetic HTB derivative, BECT inhibits lipopolysaccharide-mediated inflammatory response by suppressing the p38 MAPK/JNK and NF-κB activation pathways

EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-[kappa]B Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells

Anti-neuroinflammatory Activity of a Novel Cannabinoid Derivative by Inhibiting the NF-кB Signaling Pathway in Lipopolysaccharide-Induced BV-2 Microglial Cells

Practical multidisciplinary framework for the assessment and management of patients with unexplained chronic aerodigestive symptoms

Suchergebnisse filtern